Acceptable changes in quality attributes of glycosylated biopharmaceuticals

Nat Biotechnol. 2011 Apr;29(4):310-2. doi: 10.1038/nbt.1839.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / pharmacology
  • Biological Products / standards*
  • Biomedical Technology / standards*
  • Biopharmaceutics / standards*
  • Chemical Phenomena
  • Darbepoetin alfa
  • Erythropoietin / analogs & derivatives
  • Erythropoietin / standards
  • European Union
  • Glycosylation
  • Humans
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Biological Products
  • Erythropoietin
  • Darbepoetin alfa
  • Rituximab